Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning With Cyclophosphamide-Mediated Treg Modulation and Interleukin-2

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1688
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cyclophosphamide Facilitates Antitumor Efficacy Against Subcutaneous Tumors Following Intravenous Delivery of Reovirus

Clinical Cancer Research
Cancer ResearchOncology
2008English

Achieving Systemic Delivery of Oncolytic Viruses

Expert Opinion on Drug Delivery
Pharmaceutical Science
2019English

Cytokine-Induced Killer Cell Delivery Enhances the Antitumor Activity of Oncolytic Reovirus

PLoS ONE
Multidisciplinary
2017English

Systemic Therapy With Oncolytic Myxoma Virus Cures Established Residual Multiple Myeloma in Mice

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Localized Oncolytic Virotherapy Inflames Distant Tumors and Synergizes With Immune Checkpoint Blockade Leading to Systemic Tumor Rejection

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Improved Oncolytic Virotherapy by Increasing Virus Spread Within Tumors.

English

Using Clinically Approved Cyclophosphamide Regimens to Control the Humoral Immune Response to Oncolytic Viruses

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Oncolytic Virotherapy: Molecular Targets in Tumor-Selective Replication and Carrier Cell-Mediated Delivery of Oncolytic Viruses

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2008English

Efficacy of Reovirus Therapy Combined With Cyclophosphamide and Gene-Modified Cell Vaccines on Tumors Induced in Mice by HPV16-transformed Cells

International Journal of Oncology
Cancer ResearchOncology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy